CD19 and acute lymphoblastic leukemia: Nalm-6 WT cells, a CD19-positive acute lymphocytic leukemia cell line, and a CD19-KO Nalm-6 cell line were used as target cells to evaluate antigen-specific cytotoxicity of the CD19 CAR T-cells.